Genetic Technologies Ltd. engages in the provision of molecular risk assessment tests for cancer. The company is headquartered in Melbourne, Victoria and currently employs 58 full-time employees. The firm is engaged in providing genomics-based tests on health, wellness and serious disease through its EasyDNA brand. The firm offers cancer predictive testing and assessment tools to help physicians to improve health outcomes for people around the world. The firm has a proprietary risk stratification platform that integrates clinical and genetic risk to deliver outcomes to physicians and individuals. The firm's segments include EasyDNA and AffinityDNA. EasyDNA segment relates to EasyDNA branded test sales and expenses. AffinityDNA segment relates to AffinityDNA branded test sales and expenses.
Follow-Up Questions
GNTLF 股票的價格表現如何？
GNTLF 的當前價格為 $0，在上個交易日 decreased 了 0%。
Genetic Technologies Ltd 的主要業務主題或行業是什麼？
Genetic Technologies Ltd 屬於 Life Sciences Tools & Services 行業，該板塊是 Health Care
